Business Description
![Axonics Inc Axonics Inc logo](https://static.gurufocus.com/logos/0C0000BIUF.png?14)
Axonics Inc
NAICS : 334510
SIC : 3841
ISIN : US05465P1012
Description
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 10.58 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | 2.34 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 20.88 | |||||
Beneish M-Score | -2.75 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 35.3 | |||||
3-Year FCF Growth Rate | 63.6 | |||||
3-Year Book Growth Rate | 20.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 88.37 | |||||
Future 3-5Y Total Revenue Growth Rate | 20 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.43 | |||||
9-Day RSI | 63.31 | |||||
14-Day RSI | 64.03 | |||||
6-1 Month Momentum % | -0.37 | |||||
12-1 Month Momentum % | 23.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.96 | |||||
Quick Ratio | 7.11 | |||||
Cash Ratio | 6.01 | |||||
Days Inventory | 313.74 | |||||
Days Sales Outstanding | 46.67 | |||||
Days Payable | 59.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.3 | |||||
Shareholder Yield % | -0.46 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.89 | |||||
Operating Margin % | -1.25 | |||||
Net Margin % | -0.42 | |||||
FCF Margin % | 4.63 | |||||
ROE % | -0.27 | |||||
ROA % | -0.24 | |||||
ROIC % | 1.28 | |||||
ROC (Joel Greenblatt) % | 1.19 | |||||
ROCE % | 0.21 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 280.28 | |||||
PE Ratio without NRI | 584.32 | |||||
Price-to-Owner-Earnings | 1029.1 | |||||
PS Ratio | 8.47 | |||||
PB Ratio | 5.47 | |||||
Price-to-Tangible-Book | 7.51 | |||||
Price-to-Free-Cash-Flow | 181.93 | |||||
Price-to-Operating-Cash-Flow | 133.88 | |||||
EV-to-EBIT | 2368.19 | |||||
EV-to-EBITDA | 231.43 | |||||
EV-to-Forward-EBITDA | -59.45 | |||||
EV-to-Revenue | 7.86 | |||||
EV-to-Forward-Revenue | 7.05 | |||||
EV-to-FCF | 169.86 | |||||
Price-to-Graham-Number | 13.96 | |||||
Price-to-Net-Current-Asset-Value | 8.62 | |||||
Price-to-Net-Cash | 14.7 | |||||
Earnings Yield (Greenblatt) % | 0.04 | |||||
FCF Yield % | 0.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AXNX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Axonics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 408.809 | ||
EPS (TTM) ($) | -0.04 | ||
Beta | 0.77 | ||
Volatility % | 20.92 | ||
14-Day RSI | 64.03 | ||
14-Day ATR ($) | 0.337792 | ||
20-Day SMA ($) | 68.6875 | ||
12-1 Month Momentum % | 23.13 | ||
52-Week Range ($) | 48.3 - 69.68 | ||
Shares Outstanding (Mil) | 51.12 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Axonics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Axonics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Axonics Inc Frequently Asked Questions
What is Axonics Inc(AXNX)'s stock price today?
The current price of AXNX is $68.95. The 52 week high of AXNX is $69.68 and 52 week low is $48.30.
When is next earnings date of Axonics Inc(AXNX)?
The next earnings date of Axonics Inc(AXNX) is 2024-10-30 Est..
Does Axonics Inc(AXNX) pay dividends? If so, how much?
Axonics Inc(AXNX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |